DrugDashboards

nasal decongestant

Pseudoephedrine Hydrochloride · PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 · Tablet, Extended Release · Oral · Strategic Sourcing Services

NDC 70677-0001-01 · 1 BLISTER PACK in 1 CARTON / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · ANDA · View full market →

The short version

7 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.2805 per unit over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.2$0.4Nov 2018Sep 2026$0.2805
95 price points · per EASource: CMS NADAC

Estimated fill cost

#30 count
$8.42
#90 count
$25.25

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2023)

$3,090
267 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for pseudoephedrine hydrochloride (oral solid) in the next 90 days

sole-source market · price up 4% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA077442
TE code
Approval date
Sep 28, 2005
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Pseudoephedrine Hydrochloride (Tablet, Extended Release)

LabelerStrengthFirst seenLast seen
Aurohealth LLCPSEUDOEPHEDRINE HYDROCHLORIDE 240 mg/1Jul 15, 2026Sep 2, 2026
Discount Drug MartPSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 2, 2026
HebPSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 2, 2026
Ohm Laboratories Inc.PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 2, 2026
Strategic Sourcing ServicesPSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 2, 2026
Strategic Sourcing Services LlcPSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1Jul 15, 2026Sep 2, 2026
Walgreen Co.PSEUDOEPHEDRINE HYDROCHLORIDE 240 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "nasal decongestant — NDC 70677-0001-01," retrieved September 3, 2026, https://drugdashboards.com/drug/70677000101.

Free to cite with attribution — see how the data is put together.